Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dejian Ma

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Molecular Pharmacology|May 3, 2019
Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor EfficacyKinsie E Arnst, Yuxi Wang, Zi-Ning Lei, et al.
Cancer Letters|June 7, 2024
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancerDamilola Oluwalana, Kelli L Adeleye, Raisa I Krutilina, et al.
Journal of Medicinal Chemistry|March 11, 2026
Novel Triazoloquinoxaline-Based Tubulin Polymerization Inhibitor Induces Necroptosis and Significantly Inhibits Metastatic Melanoma Tumor GrowthChristopher J Clark, Shelby N Waddell, Garrett E Tessmer, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Molecular Pharmacology|May 3, 2019
Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor EfficacyKinsie E Arnst, Yuxi Wang, Zi-Ning Lei, et al.
Cancer Letters|June 7, 2024
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancerDamilola Oluwalana, Kelli L Adeleye, Raisa I Krutilina, et al.
Journal of Medicinal Chemistry|March 11, 2026
Novel Triazoloquinoxaline-Based Tubulin Polymerization Inhibitor Induces Necroptosis and Significantly Inhibits Metastatic Melanoma Tumor GrowthChristopher J Clark, Shelby N Waddell, Garrett E Tessmer, et al.
Pageof 6